The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Leading Boldly Fundraising Campaign Makes Tremendous Progress

The Leading Boldly Fundraising Campaign Makes Tremendous Progress

December 14, 2020 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Nikki Zalewski / shutterstock.com

Nikki Zalewski / shutterstock.com

In 2018, the Rheumatology Research Foundation embarked on its third and most ambitious fundraising campaign, the Leading Boldly: Transforming Rheumatology campaign, with a goal of raising $75 million over five years. The campaign supports Foundation programs to recruit the best and brightest into the field, train rheumatology health professionals at all career stages and support investigators conducting research that will lead us to more options for people with rheumatic disease.

You Might Also Like
  • Leading Boldly: Transforming Rheumatology Campaign Makes Progress
  • Rheumatology Research Foundation Launches $75M Fundraising Push
  • Rheumatology Research Foundation Fundraising Campaign Exceeds $60M Goal
Explore This Issue
December 2020
Also By This Author
  • Coding Corner Answer

“The progress of the Leading Boldly campaign demonstrates the commitment rheumatology professionals have to impacting patient care through research and training,” says Mary Wheatley, IOM, CAE, the Foundation’s executive director. “By working together to support the future of this field, we are well on our way to achieving a monumental milestone that will serve generations to come.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Thanks to support from more than 3,100 individual donors, the Foundation is leading the way in tackling rheumatology’s challenges and working toward discoveries that could impact the lives of millions of people living with rheumatic disease. As of July 31, the campaign had raised over $64.3 million, putting it at 86% of its goal.

The Foundation applauds every donor who has played a role in the campaign’s success. A great deal of gratitude is owed to the members of the Corporate Roundtable. Their participation and generosity are a direct investment in the Foundation’s mission. Members of the Corporate Roundtable include AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Genentech, Gilead, GlaxoSmithKline, Novartis, Pfizer, UCB, Bristol Myers Squibb, Janssen, Mallinckrodt, Regeneron and Sanofi.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Advancing science that will have a remarkable impact on the lives of people with rheumatic diseases is what drives all of us at AbbVie,” says Jim Salanty, vice president, U.S. Rheumatology, AbbVie. “The Leading Boldly campaign’s focus on innovative research and training efforts for healthcare professionals are more important than ever, especially in light of the challenges the community is facing right now. We are honored to partner with the Rheumatology Research Foundation.”

Amgen is also an integral supporter of the Foundation’s awards and grants program. “We are very proud to be supporting the Rheumatology Research Foundation in their strong efforts to advance innovative research and develop future rheumatologists to improve the care of patients with rheumatic diseases,” says James Chung, MD, PhD, Amgen’s executive medical director and head of inflammation/neuroscience in the global medical organization.

Members of the Pinnacle Society, Cornerstone Society, Founders Circle and Champion Circle are also acknowledged for their extraordinary dedication to the specialty. Their commitment will result in significant advancements for rheumatology research and education initiatives.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

By convening partners in academia, medicine, industry and philanthropy, the Foundation leads the way in tackling rheumatology’s challenges and working toward discoveries that could affect the lives of millions of patients. Together, we have the opportunity to make great strides in our shared mission, but the need is ongoing. Join us in this transformational initiative to shift the landscape of rheumatology.

Filed Under: From the College Tagged With: Fundraising, Rheumatology Research FoundationIssue: December 2020

You Might Also Like:
  • Leading Boldly: Transforming Rheumatology Campaign Makes Progress
  • Rheumatology Research Foundation Launches $75M Fundraising Push
  • Rheumatology Research Foundation Fundraising Campaign Exceeds $60M Goal
  • Rheumatology Research Foundation’s Campaign to Advance Patient Care Ahead of Schedule

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.